Stay updated on SAR442168 Dose-finding in MS Clinical Trial
Sign up to get notified when there's something new on the SAR442168 Dose-finding in MS Clinical Trial page.

Latest updates to the SAR442168 Dose-finding in MS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial related to SAR442168 in relapsing multiple sclerosis, while a new revision number has been added.SummaryDifference18%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
Stay in the know with updates to SAR442168 Dose-finding in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR442168 Dose-finding in MS Clinical Trial page.